Cargando…
Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction
A restoration of low homoarginine (hArg) levels in obese ZSF1 rats (O-ZSF1) before (S1-ZSF1) and after (S2-ZSF1) the manifestation of heart failure with preserved ejection fraction (HFpEF) did not affect the worsening of cardiac HFpEF characteristics. Here, potential regulation of key enzymes of arg...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572665/ https://www.ncbi.nlm.nih.gov/pubmed/37834229 http://dx.doi.org/10.3390/ijms241914782 |
_version_ | 1785120286415257600 |
---|---|
author | Büttner, Petra Werner, Sarah Böttner, Julia Ossmann, Susann Schwedhelm, Edzard Thiele, Holger |
author_facet | Büttner, Petra Werner, Sarah Böttner, Julia Ossmann, Susann Schwedhelm, Edzard Thiele, Holger |
author_sort | Büttner, Petra |
collection | PubMed |
description | A restoration of low homoarginine (hArg) levels in obese ZSF1 rats (O-ZSF1) before (S1-ZSF1) and after (S2-ZSF1) the manifestation of heart failure with preserved ejection fraction (HFpEF) did not affect the worsening of cardiac HFpEF characteristics. Here, potential regulation of key enzymes of arginine metabolism in other organs was analyzed. Arginase 2 (ARG2) was reduced >35% in the kidney and small intestine of hArg-supplemented rats compared to O-ZSF1. Glycine amidinotransferase (GATM) was 29% upregulated in the kidneys of S1-ZSF1. Dimethylarginine dimethylaminohydrolase 1 (DDAH1) levels were reduced >50% in the livers of O-ZSF1 but restored in S2-ZSF1 compared to healthy rats (L-ZSF1). In the skeletal muscle, iNOS was lower in O-ZSF1 and further decreased in S1-ZSF1 and S2-ZSF1 compared to L-ZSF1. iNOS levels were lower in the liver of the S2-ZSF1 group but higher in the kidneys of S1-ZSF1 compared to L-ZSF1. Supplementation with hArg in an in vivo HFpEF model resulted in the inhibition of renal ARG2 and an increase in GATM expression. This supplementation might contribute to the stabilization of intestinal iNOS and ARG2 imbalances, thereby enhancing barrier function. Additionally, it may offer protective effects in skeletal muscle by downregulating iNOS. In the conceptualization of hArg supplementation studies, the current disease progression stage as well as organ-specific enzyme regulation should be considered. |
format | Online Article Text |
id | pubmed-10572665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105726652023-10-14 Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction Büttner, Petra Werner, Sarah Böttner, Julia Ossmann, Susann Schwedhelm, Edzard Thiele, Holger Int J Mol Sci Communication A restoration of low homoarginine (hArg) levels in obese ZSF1 rats (O-ZSF1) before (S1-ZSF1) and after (S2-ZSF1) the manifestation of heart failure with preserved ejection fraction (HFpEF) did not affect the worsening of cardiac HFpEF characteristics. Here, potential regulation of key enzymes of arginine metabolism in other organs was analyzed. Arginase 2 (ARG2) was reduced >35% in the kidney and small intestine of hArg-supplemented rats compared to O-ZSF1. Glycine amidinotransferase (GATM) was 29% upregulated in the kidneys of S1-ZSF1. Dimethylarginine dimethylaminohydrolase 1 (DDAH1) levels were reduced >50% in the livers of O-ZSF1 but restored in S2-ZSF1 compared to healthy rats (L-ZSF1). In the skeletal muscle, iNOS was lower in O-ZSF1 and further decreased in S1-ZSF1 and S2-ZSF1 compared to L-ZSF1. iNOS levels were lower in the liver of the S2-ZSF1 group but higher in the kidneys of S1-ZSF1 compared to L-ZSF1. Supplementation with hArg in an in vivo HFpEF model resulted in the inhibition of renal ARG2 and an increase in GATM expression. This supplementation might contribute to the stabilization of intestinal iNOS and ARG2 imbalances, thereby enhancing barrier function. Additionally, it may offer protective effects in skeletal muscle by downregulating iNOS. In the conceptualization of hArg supplementation studies, the current disease progression stage as well as organ-specific enzyme regulation should be considered. MDPI 2023-09-30 /pmc/articles/PMC10572665/ /pubmed/37834229 http://dx.doi.org/10.3390/ijms241914782 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Büttner, Petra Werner, Sarah Böttner, Julia Ossmann, Susann Schwedhelm, Edzard Thiele, Holger Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction |
title | Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction |
title_full | Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction |
title_fullStr | Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction |
title_full_unstemmed | Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction |
title_short | Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction |
title_sort | systemic effects of homoarginine supplementation on arginine metabolizing enzymes in rats with heart failure with preserved ejection fraction |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572665/ https://www.ncbi.nlm.nih.gov/pubmed/37834229 http://dx.doi.org/10.3390/ijms241914782 |
work_keys_str_mv | AT buttnerpetra systemiceffectsofhomoargininesupplementationonargininemetabolizingenzymesinratswithheartfailurewithpreservedejectionfraction AT wernersarah systemiceffectsofhomoargininesupplementationonargininemetabolizingenzymesinratswithheartfailurewithpreservedejectionfraction AT bottnerjulia systemiceffectsofhomoargininesupplementationonargininemetabolizingenzymesinratswithheartfailurewithpreservedejectionfraction AT ossmannsusann systemiceffectsofhomoargininesupplementationonargininemetabolizingenzymesinratswithheartfailurewithpreservedejectionfraction AT schwedhelmedzard systemiceffectsofhomoargininesupplementationonargininemetabolizingenzymesinratswithheartfailurewithpreservedejectionfraction AT thieleholger systemiceffectsofhomoargininesupplementationonargininemetabolizingenzymesinratswithheartfailurewithpreservedejectionfraction |